Markets are shifting focus from geopolitical developments to the Q1 FY27 earnings season, with the first set of corporate results expected over the next two weeks. According to reports from ET Now, the US-Iran conflict remained in focus over the weekend, but its impact on crude oil prices and Indian equity benchmarks was limited. On Monday, the Sensex and Nifty witnessed some volatility, with analysts attributing part of the decline to profit booking after recent gains and weakness in select heavyweight stocks.
According to an analysis by The Economic Times based on Refinitiv's Stock Reports Plus dated June 29, 2026, five stocks have registered an improvement in their average scores over the past month. The screening covered stocks listed on the BSE and NSE using Refinitiv's scoring algorithms, with ET filtering to include only companies with analyst consensus ratings of 'Strong Buy,' 'Buy,' or 'Hold' while considering their estimated 12-month upside potential. The shortlisted stocks span sectors including pharmaceuticals, retail, power and others, with these companies having undergone a correction and showing signs of recovery alongside the broader market.
The five recommended stocks show significant upside potential ranging from 13% to 28% over the next 12 months. As reported by ET Now, the top pick is Akums Drugs & Pharma with a 'Strong Buy' recommendation and 28% upside potential, followed by Torrent Power ('Hold' rating, 20% upside), Linde India ('Hold', 17% upside), Mishra Dhatu Nigam ('Strong Buy', 16% upside), and Trent ('Buy', 13% upside). Market participants are now focusing on the upcoming June quarter earnings season, with investors closely monitoring earnings across sectors for signs of the impact of elevated crude oil prices and supply chain disruptions during the quarter.
The market's reaction to the upcoming Q1 FY27 earnings will be closely watched, particularly in companies that do not report earnings surprises. According to ET Now, analysts noted that a limited reaction to weaker-than-expected earnings may indicate that investors have largely factored in the expected pressure on corporate performance. On the other hand, a broader sell-off following disappointing results could signal that concerns over earnings remain elevated. With the Q1 earnings season set to gather pace in the coming weeks, investors are expected to closely track corporate commentary and market sentiment for cues on the near-term direction of equities.
